Pancrelipase

Pancytopenia is a medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets. Pancytopenia is generally due to diseases affecting the bone marrow, although peripheral destruction of all lines of blood cells in hypersplenism is a recognised cause. Bone marrow problems causing pancytopenia include myelofibrosis, leukemia, aplastic anemia, and the malignant form of osteoporosis.Chemotherapy for malignancies may also cause pancytopenia, if the drug or drugs used cause bone marrow suppression. Increasingly, HIV is itself a cause for pancytopenia.Rarely, drugs can cause pancytopenia.Pancytopenia usually requires a bone marrow biopsy in order to distinguish among different causes. (From the Wikpedia article Pancrelipase.)

Download PDF containing detailed information.

Recent Publications on Pancrelipase:
Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study. OBJECTIVES: To evaluate the efficacy and safety of a pancreatic enzyme...	5th November, 2009	CF Center of Milano, Fondazione IRCCS Ospedale Policlinico, Mangiagalli,	Pancreas. 2009 Aug;38(6):693-9. DOI Direct Link
Pharmacokinetics of erlotinib for the treatment of high-grade glioma in a pediatric patient with cystic fibrosis: case report and review of the literature. A 12-year-old girl with cystic fibrosis was diagnosed with a high-grade...	3rd September, 2009	Department of Pharmaceutical Services, St. Jude Children's Research	Pharmacotherapy. 2009 Jul;29(7):858-66. DOI Direct Link
Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis. Pancreatic enzyme supplements (PES) are used in chronic pancreatitis (CP)...	27th August, 2009	Johns Hopkins University School of Medicine; Department of Medicine.	Ther Clin Risk Manag. 2009 Jun;5(3):507-20. Epub 2009 Jul 12.
EUR-1008 pancreatic enzyme replacement is safe and effective in patients with cystic fibrosis and pancreatic insufficiency. BACKGROUND: EUR-1008 (Zenpep [pancrelipase]) is a new, enteric-coated,...	18th August, 2009	Cincinnati Children's Hospital Medical Center, Division of Pulmonary	J Cyst Fibros. 2009 Aug 14. DOI Direct Link
First FDA-approved pancrelipase product may mark new era for providers, patients. OBJECTIVES: To evaluate the efficacy and safety of a pancreatic enzyme...	12th August, 2009		Am J Health Syst Pharm. 2009 Jun 15;66(12):1066, 1068. DOI Direct Link
→View more research publications.

Press Releases About Pancrelipase:
Results Published In Journal of Cystic Fibrosis Confirm CREON(R) (pancrelipase) Delayed-Release Capsules Improves Fat Absorption in Patients With Cystic Fibrosis	9th October, 2009	Solvay Pharmaceuticals, Inc.	MARIETTA, Ga., Oct. 9 /PRNewswire/ -- Solvay Pharmaceuticals, Inc. announced today that Phase III data published in the Journal of Cystic Fibrosis showed that CREON® (pancrelipase) Delayed-Release
40 High-Achieving Students with Cystic Fibrosis Receive $100,000 Total in Higher Education Scholarships From SolvayCARES(SM)	15th September, 2008	Solvay Pharmaceuticals, Inc.	MARIETTA, Ga., Sept. 15 /PRNewswire/ -- Solvay Pharmaceuticals, Inc. has awarded scholarships totaling $100,000 to 40 students living with cystic fibrosis (CF) through its SolvayCARES Scholarship

BioNews Results for Pancrelipase:
FDA Pipeline preview, October 2009 (Eplivanserin, Pancrelipase, Trabectedin, Clofarabine, Fampridine-SR, Collagenase clostridium histolyticum, Oxycodone reformulated, Pegylated interferon alfa-2b, Maraviroc, Armodafinil, Relaxin, Perifosine, Glyc	Modern Medicine:  Nov 20 2009 4:54PM Matching: pancrelipase
FDA Pipeline preview, October 2009 (Eplivanserin, Pancrelipase, Trabectedin, Clofarabine, Fampridine-SR, Colla	Formulary Journal:  Nov 20 2009 3:14PM Matching: pancrelipase
Phase II/III Clinical Study Compares Safety and Efficacy of Two Doses of ZENPEP(TM) (Pancrelipase) Delayed-Rel	Genetic Engineering News:  Nov 13 2009 2:22PM Matching: pancrelipase
Eurand Reports Key Achievements and Strong Revenue Growth for Third Quarter 2009	Street Insider:  Nov 5 2009 4:17PM Matching: pancrelipase
Eurand Reports Key Achievements and Strong Revenue Growth for Third Quarter 2009	Genetic Engineering News:  Nov 5 2009 12:25PM Matching: pancrelipase
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Pancrelipase Patents:
US Patent No.	Title
6669961	Microparticles
7038085	Stereoisomers of p-hydroxy-milnacipran, and methods of use thereof
7052913	Matrices for drug delivery and methods for making and using the same
7090867	Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
7122198	Fast dissolving composition with prolonged sweet taste
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Pancrelipase scientists - we have details of around 18 individuals working on Pancrelipase .